Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Springboard Capital II is a Danish venture capital fund and investment firm that specializes in the life sciences and technology sectors. The firm focuses on providing growth capital and strategic support to early-stage and mid-stage companies, particularly those developing innovative healthcare solutions and medical technologies. By leveraging a deep network of industry experts and academic collaborations, Springboard Capital II aims to accelerate the commercialization of high-potential biotech and medtech ventures. The firm is known for its active involvement in its portfolio companies, offering guidance on business development, regulatory pathways, and international expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Springboard Capital II.